Comment on “Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma”
Journal of Pharmaceutical Analysis · 2026-11 · 101831
DOI: 10.1016/j.jpha.2026.101831 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-11. Verfasst von Zhaoxian Yan und 2 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Yan, Z., Hong, J., & Ling, C. (2026). Comment on “Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma”. Journal of Pharmaceutical Analysis, 101831. https://doi.org/10.1016/j.jpha.2026.101831
Vancouver
Yan Z, Hong J, Ling C. Comment on “Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma”. Journal of Pharmaceutical Analysis. 2026:101831. doi:10.1016/j.jpha.2026.101831
BibTeX
@article{Yan2026,
author = {Yan, Zhaoxian and Hong, Jing and Ling, Changquan},
title = {Comment on “Ginsenoside Rk3 is a novel PI3K/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma”},
journal = {Journal of Pharmaceutical Analysis},
year = {2026},
pages = {101831},
doi = {10.1016/j.jpha.2026.101831}
}
EUVIMED